APA (7th ed.) Citation

Joensuu, H., Blay, J., Comandone, A., Martin-Broto, J., Fumagalli, E., Grignani, G., . . . Le Cesne, A. (2017). Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib. British Journal of Cancer, 117(9), 1278. https://doi.org/10.1038/bjc.2017.290

Chicago Style (17th ed.) Citation

Joensuu, Heikki, et al. "Dovitinib in Patients with Gastrointestinal Stromal Tumour Refractory And/or Intolerant to Imatinib." British Journal of Cancer 117, no. 9 (2017): 1278. https://doi.org/10.1038/bjc.2017.290.

MLA (9th ed.) Citation

Joensuu, Heikki, et al. "Dovitinib in Patients with Gastrointestinal Stromal Tumour Refractory And/or Intolerant to Imatinib." British Journal of Cancer, vol. 117, no. 9, 2017, p. 1278, https://doi.org/10.1038/bjc.2017.290.